Tectonic Therapeutic, Inc.

NASDAQ:TECX

Biotechnology

Healthcare
$21.04 -0.96%

-$0.29 today

Market cap
$411.32M
Beta
1.22
P/E (TTM)
-6.7
EPS (TTM)
-$4.45
52W Low $14.39High $36.03

Volume 0.17M

Average 0.20M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$60.08M

FY 2025 · Annual

Investing Cash Flow

-$138,000.00

FY 2025 · Annual

Financing Cash Flow

$173.35M

FY 2025 · Annual

+1.0% YoY

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(8.93M)(32.18K)(42.82M)(57.98M)(74.15M)
Depreciation & Amortization364K1.01K1.48M1.65M1.38M
Deferred Income Tax00000
Stock-Based Compensation639K1.12K1.12M3.49M10.5M
Change in Working Capital1.92M(7.4M)(584K)(10.28M)(70K)
Accounts Receivables00000
Inventory00000
Accounts Payables1.45M(3.1M)(165K)(1.42M)116K
Other Working Capital464K(4.3M)(419K)(8.86M)(186K)
Other Non-Cash Items(6.45M)(89.78M)127K4.04M2.27M
Operating Cash Flow(12.45M)(97.21M)(40.68M)(59.08M)(60.08M)
Capital Expenditures(2.12M)(267K)(279K)(156K)(208K)
Acquisitions (Net)000070K
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities00000
Investing Cash Flow(2.12M)(267K)(279K)(156K)(138K)
Debt Repayment3.61M(393K)(499K)(475K)(489K)
Common Stock Issued2K262K34.13M94.6M174.33M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities0393K121K77.59M(485K)
Financing Cash Flow41.42M262K33.75M171.71M173.36M
Effect of Forex Changes0492K16K(8K)(95K)
Net Change in Cash26.84M(96.72M)(7.2M)112.47M113.04M
Free Cash Flow(14.58M)(97.48M)(40.96M)(59.24M)(60.29M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$74.2M
+ D&A$1.4M
+ Stock-Based Comp$10.5M
+ Deferred Tax$0
- Working Capital-$70.0K
+ Other Non-Cash$2.3M
= Operating Cash Flow-$60.1M
- Capex-$208.0K
= Free Cash Flow-$60.3M

Analysis

FY2025 free cash flow is -$60.3M. FCF conversion is 81.3% of net income. Operating cash flow was -$60.1M, with capex of -$208.0K. The largest bridge item is Stock-Based Comp at $10.5M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 5, 2026
10-QQuarterly reportNov 5, 2026
SC 13G/ASC 13G/A filingOct 29, 2026
4Statement of changes in beneficial ownershipOct 28, 2026
4Statement of changes in beneficial ownershipOct 2, 2026

Does TECX generate free cash flow?

Tectonic Therapeutic, Inc. (TECX) generated -$60.29M of free cash flow in fiscal 2025.

How much operating cash flow does TECX produce?

Operating cash flow was -$60.08M, before capital expenditures of $208,000.00.